Submit Deal

ABCELLERA

Summary

AbCellera is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies to address pandemics and common diseases.

Deals Overview

Total Deals4

Valued Deals2

Total Value£ 151 M

Avg. Deal Size£ 76 M

Market Context

Senior Management

Carl Hansen
CEO
Andrew Booth
CFO
Kevin Heyries
Co-Founder and Head of Business Development

Sort

27 May 2020|Canada|Biotechnology

Target: ABCELLERA

Bidder: ORBIMED PE

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 85 M

Value

20 Aug 2020|Canada|Biotechnology

Target: ORTHOMAB

Bidder: ABCELLERA

1 Service Providers

1 Bidder

1 Dealmakers

1 Bidder

n/a

Value

18 Nov 2020|Canada|Biotechnology

Target: TRIANNI

Bidder: ABCELLERA

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 65 M

Value

13 Sep 2021|United States|Biotechnology

Target: TETRAGENETICS INC

Bidder: ABCELLERA

4 Service Providers

2 Target | 2 Bidder

6 Dealmakers

1 Target | 5 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Carl Hansen
CEO
Andrew Booth
CFO
Kevin Heyries
Co-Founder and Head of Business Development